Financial statements Pharmalek-Jet
Balance sheet data of PHARMALEK-JET
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 6 407 874,46 | 6 497 441,06 | 7 133 432,61 | 8 536 639,77 | 8 106 115,76 | 7 085 686,30 |
| A. Fixed assets | 4 852 536,80 | 4 843 255,69 | 4 838 245,21 | 5 692 323,11 | 5 829 367,91 | 4 824 676,23 |
| B. Current assets | 1 555 337,66 | 1 654 185,37 | 2 295 187,40 | 2 844 316,66 | 2 276 747,85 | 2 261 010,07 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 6 407 874,46 | 6 497 441,06 | 7 133 432,61 | 8 536 639,77 | 8 106 115,76 | 7 085 686,30 |
| A. Equity | 5 195 945,31 | 5 211 984,42 | 5 356 515,30 | 5 601 012,50 | 5 592 498,51 | 5 376 612,65 |
| B. Liabilities and provisions for liabilities | 1 211 929,15 | 1 285 456,64 | 1 776 917,31 | 2 935 627,27 | 2 513 617,25 | 1 709 073,65 |
| I. Long-term liabilities | - | 70 000,00 | 454 257,00 | 1 361 420,72 | 952 948,95 | 270 309,39 |
| II. Short-term liabilities | 1 183 724,39 | 1 189 711,88 | 1 296 915,55 | 1 548 461,79 | 1 207 248,54 | 1 385 344,50 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.